Pluto Bioinformatics

GSE79671: Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

Bulk RNA sequencing

Purpose: To identify transcriptional changes by RNA-seq in tumor samples, before bevacizumab combination treatment and after bevacizumab combination treatment in both responding and non-responding recurrent glioblastoma patients SOURCE: Kristoffer Vitting-Seerup University of Copenhagen